Non-alcoholic steatohepatitis (NASH) is a chronic liver disease often associated with diabetes. However, it is unclear how NASH develops and there is currently no approved medication for the disease. A research group including Members of Kobe University’s Graduate School of Medicine has clarified the mechanism behind NASH and diabetes. It is hoped that the pathway uncovered in this study will provide potential target for the development of new medications for these conditions.
- ‘Silent epidemic of grief’ leaves bereaved and bereavement care practitioners struggling
- Sensing suns
- Predicts the onset of Alzheimer’s Disease (AD) using deep learning-based Splice-AI
- When foams collapse (and when they don’t)
- Oahu marine protected areas offer limited protection of coral reef herbivorous fishes